Advertisement
Loading...

Mainz Biomed N.V.

QUCY•NASDAQ
Healthcare
Medical - Diagnostics & Research
$3.46
$0.46(15.33%)
U.S. Market opens in 39h 30m

Mainz Biomed N.V. (QUCY) Stock Overview

Explore Mainz Biomed N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap43.7M
P/E Ratio-0.15
EPS (TTM)$-22.36
ROE-4.66%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

QUCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mainz Biomed N.V. (QUCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 96.09, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.15 and a market capitalization of 43.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
16.33%
5-Day Change
841.46%
1-Month Change
538.61%
3-Month Change
336.25%
6-Month Change
336.25%
Year-to-Date (YTD) Change
336.25%
1-Year Change
336.25%
3-Year Change
336.25%
5-Year Change
336.25%
All-Time (Max) Change
336.25%

Contact Information

http://mainzbiomed.com
49 6131 554 2860
Robert Koch Strasse 50, Mainz, NaN, 55129

Company Facts

26 Employees
IPO DateNov 5, 2021
CountryDE
Actively Trading

Frequently Asked Questions